22 results on '"W. Y. Kim"'
Search Results
2. P494 The efficacy and safety of adalimumab for patients with moderately to severely active ulcerative colitis and predictors of response in Korea
- Author
-
S Shin Shin, S J Park, Y Kim, J P Im, H J Kim, K M Lee, J W Kim, S A Jung, J Lee, S B Kang, S J Shin, E S Kim, Y S Kim, T O Kim, H S Kim, D I Park, H K Kim, Y H Kim, D H Kim, D Teng, J H Kim, W Y Kim, and C H Choi
- Subjects
medicine.medical_specialty ,Tumor necrosis factors ,business.industry ,medicine.medical_treatment ,Gastroenterology ,General Medicine ,medicine.disease ,Ulcerative colitis ,Pulmonary tuberculosis ,Internal medicine ,Disease remission ,Adalimumab ,Medicine ,C-reactive protein measurement ,business ,Neoadjuvant therapy ,medicine.drug - Abstract
Background The aim of this study to assess the efficacy and safety of adalimumab (ADA), a monoclonal antibody against tumour necrosis factor α (TNF-α), and to explore predictors of response in Korean patients with ulcerative colitis (UC). Methods We conducted a prospective observational multicenter study over 56 weeks in adult patients with moderately to severely active UC. Clinical response and remission were assessed by Mayo score. Mucosal healing was defined as Mayo subscore 0 or 1. Faecal calprotectin (FC) were assessed at baseline, week 8 and 56. Adalimumab drug levels were checked at week 8 and at loss of response. Missing or incomplete data were handled using the nonresponder imputation method. Results A total of 146 patients were enrolled and included in the analysis. Clinical response rates were 52.1% (76/146) and 37.7% (55/146) at week 8 and 56, respectively. Clinical remission was achieved in 24.0% (35/146) and 21.9% (32/146) of patients at week 8 and 56. Steroid-free remission rates were 21.2% (31/146) at week 56. Mucosal healing rates were 39.0% (57/146) and 30.1% (44/146) at week 8 and 56. Prior use of anti-TNF-α did not affect the clinical and endoscopic responses. Treatment persistence was achieved in 57.5% (84/146) of patients at week 56. Adalimumab drug level was significantly higher in patients with clinical response (10.8 vs. 8.0, p = 0.004), clinical remission (11.7 vs. 8.8, p = 0.007) and mucosal healing (11.0 vs. 8.5, p = 0.010) at week 8. Adalimumab dose was escalated to 40 mg weekly in 25 (17.1%) patients, and clinical response and remission were achieved in 40% and 20% of patients at week 56, respectively. Mean faecal calprotectin levels were significantly more decreased in clinical responders compared with non-responders at week 8 (336.3 mg/kg vs. 628.8 mg/kg, p < 0.001). The Fecal calprotectin levels are well correlated with endoscopic severity, and the best cut-off value to predict mucosal healing was 274 mg/kg. The lower endoscopic severity, higher body mass index and higher serum albumin level at baseline were associated with a clinical response at week 8. The lower Mayo score, lower C-reactive protein level, clinical response (74.5% vs. 38.5%, p < 0.001) and mucosal healing (52.7% vs. 30.8%, p = 0.008) at week 8 were associated with clinical response at week 56. Serious adverse drug reactions were identified in 2.7% (4/146) of patients including 1 case of pulmonary tuberculosis. Conclusion Adalimumab is safe and effective for induction and maintenance in Korean patients with UC, regardless of prior anti-TNF therapy. Adalimumab drug level is associated with the efficacy of induction therapy. A better response to induction therapy can predict a better long-term response.
- Published
- 2020
- Full Text
- View/download PDF
3. CKD LAB METHODS, PROGRESSION & RISK FACTORS 2
- Author
-
M. Onuigbo, N. Agbasi, M. J. Wu, K. H. Shu, E. Kugler, E. Cohen, I. Krause, E. Goldberg, M. Garty, J. Jansen, I. E. De Napoli, C. M. Schophuizen, M. J. Wilmer, H. A. Mutsaers, L. P. Heuvel, D. W. Grijpma, D. Stamatialis, J. G. Hoenderop, R. Masereeuw, A. H. Van Craenenbroeck, E. M. Van Craenenbroeck, K. Van Ackeren, C. J. Vrints, V. Y. Hoymans, M. M. Couttenye, M. Erkmen Uyar, E. Tutal, Z. Bal, O. Guliyev, S. Sezer, L. Liu, C. Wang, K. Tanaka, A. Kushiyama, K. Sakai, S. Hara, Y. Ubara, Y. Ohashi, Y. Kunugi, S. Kawazu, K. Untersteller, S. Seiler, K. S. Rogacev, I. E. Emrich, C. S. Lennartz, D. Fliser, G. H. Heine, T. Hoshino, S. Ookawara, H. Miyazawa, Y. Ueda, K. Ito, Y. Kaku, K. Hirai, H. Mori, I. Yoshida, S. Kakuta, N. Hayama, M. Amemiya, H. Okamoto, S. Inoue, K. Tabei, P. Campos, C. Dias, J. Baptista, A. L. Papoila, A. Ortiz, L. Inchaustegui, K. Soto, K. H. Moon, S. Yang, D.-Y. Lee, H. W. Kim, B. Kim, C. Isnard Bagnis, A. Guerraoui, F. Zenasni, L. Idier, P. Chauveau, A. Cerqueira, J. Quelhas-Santos, M. Pestana, J.-Y. Choi, D.-C. Jin, Y.-J. Choi, W.-Y. Kim, S.-A. Nam, J.-H. Cha, V. Cernaro, S. Loddo, A. Lacquaniti, A. Romeo, G. Costantino, G. Montalto, D. Santoro, D. Trimboli, C. A. Ricciardi, V. Lacava, M. Buemi, A. M. Zawada, R. Obeid, J. Geisel, G. C. Meneses, G. Silva Junior, M. F. B. Costa, H. S. Goncalves, E. F. Daher, A. B. Liborio, A. M. C. Martins, R. Ekart, N. Hojs, S. Bevc, R. Hojs, C. S. Lim, J. H. Hwang, H. J. Chin, S. Kim, D. K. Kim, J. H. Park, S. J. Shin, S. H. Lee, B. S. Choi, S. Lemoine, M. Panaye, L. Juillard, L. Dubourg, A. Hadj-Aissa, F. Guebre-Egziabher, A. P. F. Vieira, A. X. Couto Bem, M. P. Alves, G. Stefan, C. Capusa, S. Stancu, D. Margarit, L. Petrescu, E. D. Nedelcu, G. Mircescu, A. Szarejko-Paradowska, J. Rysz, C.-C. Hung, H.-C. Chen, V. Ristovska, L. Grcevska, M. A. Podesta, F. Reggiani, D. Cucchiari, S. Badalamenti, C. Ponticelli, G. Graziani, N. Nouri-Majalan, S. Moghadasimousavi, Z. Eshaghyeh, S. Greenwood, P. Koufaki, H. Maclaughlin, R. Rush, B. M. Hendry, I. C. Macdougall, T. Mercer, and H. Cairns
- Subjects
Transplantation ,medicine.medical_specialty ,Nephrology ,business.industry ,medicine ,Intensive care medicine ,business - Published
- 2014
- Full Text
- View/download PDF
4. Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma
- Author
-
S.H. Lee, W. Y. Kim, Ji-Eun Kim, Yoon Kyung Jeon, Dong Wan Kim, Yehyun Kim, Dae Seog Heo, Tae Min Kim, and Chul Woo Kim
- Subjects
Male ,Oncology ,medicine.medical_specialty ,Time Factors ,chemical and pharmacologic phenomena ,Kaplan-Meier Estimate ,Lymphoma, T-Cell ,T-Lymphocytes, Regulatory ,Disease-Free Survival ,Lymphocytes, Tumor-Infiltrating ,International Prognostic Index ,Internal medicine ,medicine ,Humans ,T-cell lymphoma ,Lymph node ,Survival analysis ,Neoplasm Staging ,Tumor microenvironment ,business.industry ,FOXP3 ,Forkhead Transcription Factors ,hemic and immune systems ,Hematology ,Middle Aged ,Prognosis ,medicine.disease ,Natural killer T cell ,Immunohistochemistry ,Survival Analysis ,Lymphoma ,medicine.anatomical_structure ,Multivariate Analysis ,Immunology ,Disease Progression ,Natural Killer T-Cells ,Female ,business ,Follow-Up Studies - Abstract
Background: Extranodal natural killer/T-cell lymphoma (NKTCL) is a clinically heterogeneous disease with a poor prognosis, requiring risk-stratified management in affected patients. Recently, tumor microenvironment including regulatory T cells (Tregs) has been implicated as a prognostic marker in certain types of lymphoma. Patients and methods: We collected 64 NKTCL cases and numerically quantified the amount of tumor-infiltrating FOXP3-positive Tregs by automated slide scanning and image analysis program after immunohistochemical staining using anti-FOXP3 antibody. Results: Patients were able to be classified into two end groups by their level of Tregs. Twenty-eight (44%) patients had Tregs
- Published
- 2009
- Full Text
- View/download PDF
5. The relationship between acetabular retroversion and osteoarthritis of the hip
- Author
-
P. D. Allen, J. G. Andrew, Charles E. Hutchinson, and W. Y. Kim
- Subjects
Adult ,Male ,musculoskeletal diseases ,medicine.medical_specialty ,Osteoarthritis ,Osteoarthritis, Hip ,Arthropathy ,Image Processing, Computer-Assisted ,medicine ,Humans ,Analysis software ,Orthopedics and Sports Medicine ,In patient ,Ossification ,business.industry ,Ossification, Heterotopic ,Reproducibility of Results ,Acetabulum ,Middle Aged ,medicine.disease ,Surgery ,Orthopedic surgery ,Female ,Hip Joint ,Acetabular retroversion ,medicine.symptom ,business ,Colonography, Computed Tomographic - Abstract
Excessive acetabular cover secondary to a retroverted acetabulum causes pincer impingement, which may cause early osteoarthritis of the hip. Our aim was to determine if there was a relationship between acetabular version and osteoarthritis of the hip. Using image processing and analysis software we studied 117 CT images of the hip in patients aged less than 65 years who had undergone a CT virtual colonoscopy. The mean CT joint space of the 18 hips with acetabular retroversion was narrower compared with the 99 hips with normal acetabular alignment (p < 0.0001). A correlation of r = 0.46 (p < 0.01) was found between right hip acetabular version and the mean right hip joint space and of r = 0.31 (p = 0.02) between left hip acetabular version and the mean left hip joint space. Acetabular retroversion is associated with radiological evidence of osteoarthritis of the hip. An understanding of the mechanical basis of osteoarthritis of the hip allows early treatment of the underlying structural abnormality and prevents progression of the degenerative condition.
- Published
- 2006
- Full Text
- View/download PDF
6. Eleven-year results of the ABG I hip replacement
- Author
-
B. N. Muddu and W. Y. Kim
- Subjects
Adult ,Male ,Reoperation ,musculoskeletal diseases ,medicine.medical_specialty ,Osteolysis ,Arthroplasty, Replacement, Hip ,medicine.medical_treatment ,Prosthesis ,Hip replacement (animal) ,Humans ,Medicine ,Orthopedics and Sports Medicine ,Femur ,Prospective Studies ,Prospective cohort study ,Aged ,Hip surgery ,Original Paper ,business.industry ,Middle Aged ,medicine.disease ,Arthroplasty ,Prosthesis Failure ,Surgery ,Polyethylene ,Orthopedic surgery ,Female ,Chromium Alloys ,Hip Prosthesis ,business ,Follow-Up Studies - Abstract
The ABG I uncemented hip prosthesis has demonstrated an unacceptably high failure rate and poor functional outcome in our patients. A prospective review was performed of 38 implanted hips with a mean follow-up of 11 years. Sixteen hips have been revised or are candidates for revision hip surgery, due principally to polyethylene wear and pelvic osteolysis. Contributing factors were likely to be the poor wear characteristics of the polyethylene liners—which were gamma irradiated in air—and the thinness of these liners. Of further concern were the poor pain and function scores in the remaining hips [mean Harris Hip Scores (HHS) of 70 (SD 22) at 11-year follow-up]. The influence of the surgical learning curve on clinical results may have been an important factor. Undersized femoral components were associated with poor pain and functional scores in five patients with HHS < 60. All ABG I hip implants must remain under careful, long-term review.
- Published
- 2006
- Full Text
- View/download PDF
7. Bovine growth hormone and milk fat synthesis : from the body to the molecule - Review
- Author
-
R. L. Baldwin, In K. Han, W. Y. Kim, and Jong K. Ha
- Subjects
medicine.medical_specialty ,Endocrinology ,Biochemistry ,Chemistry ,Internal medicine ,Milk fat ,medicine ,Acetyl-CoA carboxylase ,Molecule ,Animal Science and Zoology ,Bovine somatotropin ,Food Science - Published
- 1997
- Full Text
- View/download PDF
8. Hormonal regulation of insulin-like growth factor binding protein secretion by a bovine mammary epithelial cell line
- Author
-
W. Y. Kim, C.C. Calvert, J. C. Chow, R. L. Baldwin, M.D. Hanigan, and Jong K. Ha
- Subjects
medicine.medical_specialty ,biology ,Chemistry ,Epithelium ,Insulin-like growth factor-binding protein ,medicine.anatomical_structure ,Endocrinology ,Internal medicine ,medicine ,biology.protein ,Animal Science and Zoology ,Growth factor receptor inhibitor ,Secretion ,Line (text file) ,Food Science ,Hormone - Published
- 1997
- Full Text
- View/download PDF
9. Effects of insulin on acetyl-CoA carboxylase in bovine mammary secretory cells
- Author
-
Jong K. Ha, W. Y. Kim, and R. L. Baldwin
- Subjects
medicine.medical_specialty ,Endocrinology ,Biochemistry ,Chemistry ,Internal medicine ,Insulin ,medicine.medical_treatment ,medicine ,Acetyl-CoA carboxylase ,Animal Science and Zoology ,Food Science - Published
- 1997
- Full Text
- View/download PDF
10. The impact of saddle embolism on the major adverse event rate of patients with non-high-risk pulmonary embolism
- Author
-
M K Kwak, K S Lim, W Y Kim, S Ahn, Choong Wook Lee, Michael W. Donnino, C H Sohn, and D W Seo
- Subjects
Male ,medicine.medical_specialty ,Pulmonary Artery ,Risk Assessment ,Risk Factors ,Internal medicine ,medicine.artery ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Adverse effect ,Survival rate ,Aged ,Retrospective Studies ,medicine.diagnostic_test ,Full Paper ,business.industry ,Angiography ,Retrospective cohort study ,General Medicine ,Emergency department ,Middle Aged ,medicine.disease ,Prognosis ,Surgery ,Pulmonary embolism ,Survival Rate ,Embolism ,Pulmonary artery ,Cardiology ,Female ,business ,Pulmonary Embolism ,Tomography, X-Ray Computed - Abstract
Wider application of CT angiography (CTA) improves the diagnosis of acute pulmonary embolism (PE). It also permits the visualisation of saddle embolism (SE), namely thrombi, which are located at the bifurcation of the main pulmonary artery. The aim of this study was to assess the prevalence of SE and whether SE predicts a complicated clinical course in patients with non-high-risk PE.In total, 297 consecutive patients with non-high-risk PE confirmed using CTA in the emergency department were studied. The presence of SE and its ability to predict the occurrence of major adverse events (MAEs) within 1 month were determined.Of the 297 patients, 27 (9.1%) had an SE. The overall mortality at 1 month was 12.5%; no significant difference was observed between the SE and non-SE groups (18.5% vs 11.9%, p=0.32). However, patients with SE were more likely to receive thrombolytic therapy (29.6% vs 8.1%, p0.01) and had significantly more MAEs (59.3% vs 25.6%, p0.01).At the time of diagnosis, SE, as determined using CTA, is associated with the development of MAE within 1 month. It may be a simple method for risk stratification of patients with non-high-risk PE.The prognosis of patients with SE, especially those who are haemodynamically stable, is unclear. This study shows that patients with SE, determined with CTA, is associated with the development of MAE.
- Published
- 2013
11. Interval and strength training in CAD patients
- Author
-
Jan Hoff, Trine Karlsen, W. Y. Kim, Henrik Pedersen, J. Kværness, Steffen Ringgaard, L. Brix, Jan Helgerud, Kjetil L. Høydal, and Asbjørn Støylen
- Subjects
Male ,medicine.medical_specialty ,Strength training ,education ,Physical Exertion ,Physical Therapy, Sports Therapy and Rehabilitation ,Coronary Artery Disease ,Interval training ,Oxygen Consumption ,Endurance training ,Internal medicine ,Heart rate ,medicine ,Humans ,Orthopedics and Sports Medicine ,Leg press ,Exercise ,Ejection fraction ,business.industry ,VO2 max ,Resistance Training ,Stroke Volume ,Stroke volume ,Middle Aged ,Surgery ,Cardiology ,Quality of Life ,Female ,business - Abstract
This study sought to study the effect of high intensity aerobic interval endurance training on peak stroke volume and maximal strength training on mechanical efficiency in coronary artery disease (CAD) patients. 8 CAD patients (age 61.4 ± 3.7 years) trained 30 interval training sessions with 4 × 4 min intervals at 85-95% of peak heart rate while 10 CAD patients (age 66.5 ± 5.5 years) trained 24 sessions of maximal horizontal leg press. In the interval training group peak stroke volume increased significantly by 23% from 94.1 ± 23.0 mL · beat (-1) to 115.8 ± 22.4 mL · beat (-1) (p
- Published
- 2010
- Full Text
- View/download PDF
12. Intra-operative findings in varus osteoarthritis of the knee
- Author
-
S. Jari and W. Y. Kim
- Subjects
musculoskeletal diseases ,medicine.medical_specialty ,Intra operative ,business.industry ,medicine ,Physical therapy ,Orthopedics and Sports Medicine ,Surgery ,Osteoarthritis ,musculoskeletal system ,medicine.disease ,business ,Selection (genetic algorithm) - Abstract
Sir, We read with interest the article in the January 2004 issue by Ritter et al,[1][1] entitled ‘Intra-operative findings in varus osteoarthritis of the knee’. There is no doubt that there is a need for improvement in the methods of selection of the patients who may benefit from
- Published
- 2005
- Full Text
- View/download PDF
13. Impingement syndrome associated with whiplash injury
- Author
-
M. Zenios, W. Y. Kim, and B. N. Muddu
- Subjects
Whiplash injury ,medicine.medical_specialty ,business.industry ,Shoulder Impingement Syndrome ,Impingement syndrome ,Physical therapy ,Medicine ,Orthopedics and Sports Medicine ,Surgery ,business ,medicine.disease - Published
- 2003
- Full Text
- View/download PDF
14. P128: Ultrasonographic findings of endometrial polyp
- Author
-
W. Y. Kim Kim, J. Y. Kwak, T. H. Kwon, H. S. Hong, and E. K. Ji
- Subjects
Gynecology ,medicine.medical_specialty ,Reproductive Medicine ,Radiological and Ultrasound Technology ,business.industry ,Endometrial Polyp ,medicine ,Obstetrics and Gynecology ,Radiology, Nuclear Medicine and imaging ,General Medicine ,business - Published
- 2003
- Full Text
- View/download PDF
15. The relationship of HIF2 and the progression of PTEN-deficient mouse prostate tumors
- Author
-
W. Y. Kim, B. Zhou, and G. Thomas
- Subjects
PCA3 ,Oncology ,Cancer Research ,Intraepithelial neoplasia ,medicine.medical_specialty ,biology ,business.industry ,medicine.disease ,medicine.disease_cause ,Prostate cancer ,medicine.anatomical_structure ,Renal cell carcinoma ,Prostate ,Internal medicine ,medicine ,biology.protein ,PTEN ,business ,Carcinogenesis ,Transcription factor - Abstract
30 Background: The hypoxia-inducible factor (HIF) transcription factor has already cemented its oncogenic role in the development of renal cell carcinoma (RCC). However, its role in the tumorigenesis of other solid tumors remains unspecificed. Our studies focus on a novel link between HIF and prostate carcinogenesis. Methods: Using both in vitro cell culture studies as well as in vivo studies (orthotopic xenograft and genetically engineered mouse models) we investigate the role of HIF in prostate cancer cell proliferation, invasion, and progression. Results: Both HIF1 and HIF2 appear to be necessary for the proliferation and invasion of prostate cancer cell lines in vitro. Preliminary analysis of a PTEN deficient mouse model of prostate cancer suggests that expression of a stabilized form of HIF2 promotes the development of a larger prostate tumor burden and a more aggressive histology (high grade prostate intraepithelial neoplasia [PIN] at earlier stages). Moreover, PTEN-deficient prostate tumors producing HIF2 are more proliferative and vascular and express increased levels of genes associated with epithelial to mesenchymal transition (EMT). Conclusions: There has been much interest in the role of angiogenesis and hypoxia in prostate cancer progression. Our preliminary data suggest that HIF2 is able to promote PTEN-deficient prostate cancer progression in mice by increasing proliferation, angiogenesis, and EMT. No significant financial relationships to disclose.
- Published
- 2011
- Full Text
- View/download PDF
16. Pharmacological Preconditioning with Low-Dose Cyclosporine or FK506 Reduces Subsequent Ischemia/Reperfusion Injury in Rat Kidney. Transplantation 2001; 72: 1753
- Author
-
C. W. Yang, H. J. Ahn, H. J. Han, W. Y. Kim, C. Li, M. J. Shin, S. K. Kim, J. H. Park, Y. S. Kim, I. S. Moon, and B. K. Bang
- Subjects
Transplantation ,medicine.medical_specialty ,Renal circulation ,business.industry ,Ischemia ,Pharmacology ,medicine.disease ,Organ transplantation ,Calcineurin ,medicine.anatomical_structure ,medicine ,Transplantation Conditioning ,business ,Reperfusion injury - Published
- 2001
- Full Text
- View/download PDF
17. P02.10: The obstetric significance of single umbilical artery
- Author
-
E. K. Ji, T. H. Kwon, and W. Y. Kim
- Subjects
medicine.medical_specialty ,Reproductive Medicine ,Radiological and Ultrasound Technology ,Single umbilical artery ,Obstetrics ,business.industry ,medicine ,Obstetrics and Gynecology ,Radiology, Nuclear Medicine and imaging ,General Medicine ,medicine.disease ,business - Published
- 2006
- Full Text
- View/download PDF
18. [Untitled]
- Author
-
G.I. Kim, In-One Kim, Woo Sun Kim, and W.-Y. Kim
- Subjects
Pathology ,medicine.medical_specialty ,Acoustics and Ultrasonics ,Radiological and Ultrasound Technology ,business.industry ,Necrotizing enterocolitis ,Biophysics ,medicine ,Radiology, Nuclear Medicine and imaging ,Hypoxia (medical) ,medicine.symptom ,business ,medicine.disease - Published
- 2006
- Full Text
- View/download PDF
19. [Untitled]
- Author
-
Woo Sun Kim, W.-Y. Kim, Woochul Chang, and In-One Kim
- Subjects
medicine.medical_specialty ,Acoustics and Ultrasonics ,Radiological and Ultrasound Technology ,business.industry ,Internal medicine ,Biophysics ,medicine ,Radiology, Nuclear Medicine and imaging ,business ,Gastroenterology ,Feeding Intolerance - Published
- 2006
- Full Text
- View/download PDF
20. [Untitled]
- Author
-
E.K. Ji, Hyun Kyung Jung, T.H. Kwon, W.-Y. Kim, and Jin Young Kwak
- Subjects
Correlation ,Cystic lesion ,Pathology ,medicine.medical_specialty ,Acoustics and Ultrasonics ,Radiological and Ultrasound Technology ,business.industry ,Biophysics ,medicine ,Radiology, Nuclear Medicine and imaging ,business - Published
- 2006
- Full Text
- View/download PDF
21. The importance of leg length discrepancy after total hip arthroplasty
- Author
-
W. Y. Kim
- Subjects
medicine.medical_specialty ,business.industry ,Leg Length Inequality ,medicine.medical_treatment ,Treatment outcome ,Leg length ,Total hip replacement ,Arthroplasty ,Surgery ,Medicine ,Orthopedics and Sports Medicine ,business ,Total hip arthroplasty - Abstract
Sir, I read with interest the article by Konyves and Bannister[1][1] in the February 2005 issue entitled ‘The importance of leg length discrepancy after total hip arthroplasty’. Leg length discrepancy (LLD) is a common post-operative complication following total hip replacement and, as
- Published
- 2005
- Full Text
- View/download PDF
22. Treatment of anaemia after joint replacement
- Author
-
W. Y. Kim
- Subjects
musculoskeletal diseases ,medicine.medical_specialty ,Joint replacement ,business.industry ,hemic and lymphatic diseases ,medicine.medical_treatment ,medicine ,Knee replacement ,Orthopedics and Sports Medicine ,Surgery ,business - Abstract
Sir, I read with interest the paper by Sutton et al[1][1] in the January 2004 issue entitled ‘Treatment of anaemia after joint replacement’. The treatment of anaemia after hip or knee replacement with oral iron is common, and this paper challenges the practice. The mean level of haemoglobin
- Published
- 2005
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.